New review outlines current state of sex-sensitive issues linked to heart failure drugs

Heart failure is almost as common in women as men, but its characteristics vary by sex. A new review summarizes the current state of sex-sensitive issues related to heart failure drugs included in treatment guidelines, and suggests future directions for improved care.

The authors of the ESC Heart Failure review note that women are largely underrepresented in clinical trials of heart failure medications,and that evidence of medications' efficacy in women is limited.

"We have much hope that precision medicine will lead to more efficacious medications. I believe that this will in part be enabled by the conduct of randomized clinical trials that are more sex-aware," said co-author Dr. Marie-Pierre Dubé, of the Montreal Heart Institute Research Centre.

Source: http://newsroom.wiley.com/press-release/esc-heart-failure/sex-drugs-and-heart-failure
 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Specific HRT tablets linked to increased risk of heart disease and blood clots